All Q3 FY26 results →

DS

DCM Shriram Ltd

Q3 FY26Diversified

DCM Shriram Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,082

Market cap₹15.8K Cr

P/E11.5

Updated23 Aug 2026

Read4 min read

The short version

Company expects growth from FY '27 onwards as major chemical segment investments stabilize. The company has invested INR 4,000-5,000 crore over the last 3-4 years, expected to contribute to cash profits from FY '27 onwards.

From DCM Shriram Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Company expects growth from FY '27 onwards as major chemical segment investments stabilize.
Ongoing efforts to grow value chains across businesses to drive revenue and profit growth.
Caustic soda and chlorine demand outlook stable to positive in coming quarters, despite some large new capacities.
Fenesta business targets around 14% EBITDA margin with expanded capacity and product mix improvements.
Epichlorohydrin plant commissioning nearing completion; expect stable operations and ramp-up post Q4 FY26.
Acquisition of Hindusthan Specialty Chemicals aims for breakeven within 12 months from August 2025.
Bioseed revenues growing, with strong volumes and new product launches.
Sugar production expected to be better than last year; government support on prices and exports could improve margins.

2 more points from DCM Shriram Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

The company has invested INR 4,000-5,000 crore over the last 3-4 years, expected to contribute to cash profits from FY '27 onwards.
Earnings and profitability are expected to improve as new investments stabilize and scale up.
The epoxy and Epichlorohydrin businesses are stabilizing; profitability is anticipated from FY '27 with ramp-up in capacity and higher value product focus.
Fenesta business margins are expected to normalize around 14% EBITDA with scale and backward integration benefits.
Sugar segment profitability may remain under pressure currently due to higher costs but is supported by better recoveries and active government policy advocacy.
Overall, the company aims for steady, responsible growth with continuous operational efficiencies and digital transformation driving margin health.

2 more points from DCM Shriram Ltd's call on margins

Pro opens every point from 15K+ earnings calls

See what DCM Shriram Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The company has invested close to INR 4,000-5,000 crore in the last 3-4 years, primarily in the chemical segment.
The aluminium extrusion project at Kota is on schedule, with phase one slated to be commissioned by the end of the next quarter.
New capacities like Epichlorohydrin (ECH) plant commissioned in October 2025, with remaining balance capacity expected to be commissioned by end of current quarter.
Focus on strengthening value chain and digital transformation to build operational resilience.
Investments are aimed at stabilizing and scaling up businesses, especially chemical verticals like epoxy resins and ECH, which are expected to become profitable by FY '27.

2 more points from DCM Shriram Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Fundraising & Capital Structure

The company has not explicitly mentioned any current or immediate plans for new fundraising through debt or equity in the transcript.
Net debt as of 31st December 2025 stood at Rs 1,084 crores, increased from Rs 867 crores in the previous year, mainly due to capital expenditure and acquisitions.
The company highlighted that major investments in the chemical segment are nearing completion.

2 more points from DCM Shriram Ltd's call on fundraising

Pro opens every point from 15K+ earnings calls

See what DCM Shriram Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Fenesta Building Systems saw a slight decline in its order book during the quarter.
The decrease in Fenesta’s order book was attributed partly to product mix shifts and higher fixed costs.
Fenesta’s project vertical led the revenue growth despite the slight order book dip.
No specific figures were provided regarding the current or expected overall order book across all businesses.

- The company expects Fenesta margins to stabilize around 14% as scale and backward integration effects come into play. - Other segments like Chemicals and Sugar & Ethanol showed stable or growing demand fundamentals but no explicit order book numbers mentioned. Overall, while Fenesta's order book slightly reduced, the company continues to focus on volume growth and margin improvement; no detailed consolidated order book figures were disclosed.

2 more points from DCM Shriram Ltd's call on order book

Pro opens every point from 15K+ earnings calls

DCM Shriram Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024Q3 FY25

Mar 2025Q4 FY25

Jun 2025Q1 FY26

Sep 2025Q2 FY26

Dec 2025Q3 FY26

Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹3.2K Cr, net profit ₹371 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What DCM Shriram Ltd's management said in earlier quarters

Others in Diversified this season

Godrej Industries Ltd (Q3 FY26)
Consolidated sales revenue grew by 9% YoY in INR. Key concall takeaways from Godrej Industries Ltd's Q3 FY26 earnings call — and how it ranks against sector…
3M India Ltd (Q3 FY26)
3M India reported INR 4,446 crores in sales for FY 2024-25 (Page 7). Key concall takeaways from 3M India Ltd's Q3 FY26 earnings call — and how it ranks against…

Compare:vs Godrej Industries Ltd vs 3M India Ltd vs TTK Healthcare

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

DCM Shriram Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were DCM Shriram Ltd Q3 FY26 results?

Company expects growth from FY '27 onwards as major chemical segment investments stabilize. The company has invested INR 4,000-5,000 crore over the last 3-4 years, expected to contribute to cash profits from FY '27 onwards.

What is DCM Shriram Ltd share price analysis?

DCM Shriram Ltd currently shows a neutral. The stock trades at a P/E of 11.5 with a market cap of ₹15,750 Cr. Investors should review the full earnings analysis for detailed insights.

Is DCM Shriram Ltd planning capital expenditure?

The company has invested close to INR 4,000-5,000 crore in the last 3-4 years, primarily in the chemical segment.

Keep DCM Shriram Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.